- Home
- ALDX vs FCEL Comparison
ALDX vs FCEL Comparison
Compare ALDX & FCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- FCEL
- Stock Information
- Founded
- ALDX 2004
- FCEL 1969
- Country
- ALDX United States
- FCEL United States
- Employees
- ALDX N/A
- FCEL N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- FCEL Industrial Machinery/Components
- Sector
- ALDX Health Care
- FCEL Energy
- Exchange
- ALDX Nasdaq
- FCEL Nasdaq
- Market Cap
- ALDX 313.4M
- FCEL 369.1M
- IPO Year
- ALDX 2014
- FCEL 1992
- Fundamental
- Price
- ALDX $5.26
- FCEL $8.48
- Analyst Decision
- ALDX Strong Buy
- FCEL Hold
- Analyst Count
- ALDX 2
- FCEL 5
- Target Price
- ALDX $9.50
- FCEL $8.13
- AVG Volume (30 Days)
- ALDX 647.5K
- FCEL 5.4M
- Earning Date
- ALDX 11-06-2025
- FCEL 09-09-2025
- Dividend Yield
- ALDX N/A
- FCEL N/A
- EPS Growth
- ALDX N/A
- FCEL N/A
- EPS
- ALDX N/A
- FCEL N/A
- Revenue
- ALDX N/A
- FCEL $152,472,000.00
- Revenue This Year
- ALDX N/A
- FCEL $33.56
- Revenue Next Year
- ALDX $36.23
- FCEL $26.91
- P/E Ratio
- ALDX N/A
- FCEL N/A
- Revenue Growth
- ALDX N/A
- FCEL 78.81
- 52 Week Low
- ALDX $1.14
- FCEL $3.58
- 52 Week High
- ALDX $7.20
- FCEL $13.98
- Technical
- Relative Strength Index (RSI)
- ALDX 48.59
- FCEL 49.11
- Support Level
- ALDX $5.13
- FCEL $9.37
- Resistance Level
- ALDX $5.79
- FCEL $11.99
- Average True Range (ATR)
- ALDX 0.28
- FCEL 1.10
- MACD
- ALDX -0.00
- FCEL -0.19
- Stochastic Oscillator
- ALDX 29.10
- FCEL 25.31
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About FCEL FuelCell Energy Inc.
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products and electrolysis platforms that decarbonize power and produce hydrogen. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company operates in USA, South Korea, Europe and Canada. Majority of revenue is from USA and South Korea.